Literature DB >> 26615410

Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.

Yavuz Pehlivan1, Servet Yolbas2, Gozde Yıldırım Cetin3, Fatma Alibaz-Oner4, Yonca Cagatay5, Neslihan Yilmaz5, Serdar Oztuzcu6, Salim Donmez7, Metin Ozgen8, Suleyman Serdar Koca2, Omer Nuri Pamuk7, Mehmet Sayarlıoglu8, Bunyamin Kisacik9, Haner Direskeneli4, Abdullah Tuncay Demiryurek10, Ahmet Mesut Onat9.   

Abstract

Systemic sclerosis (SSc) is a disease characterized by inflammation, vascular abnormalities and fibrosis. The role of Rho/Rho-kinase pathway was demonstrated in the pathogenesis of fibrosis, inflammation and vascular abnormalities. This study was aimed to investigate the relation between SSc and Rho/Rho-kinase gene polymorphisms. The study included 339 patients with SSc and 302 healthy subjects who were apparently healthy and at similar age and gender. Genotype distributions and allele frequencies were detected by using Chi-square test or Fisher's exact Chi-square test between groups, and the haplotype analysis was applied using online program (SHEsis). Significant association was found in a polymorphism in the ROCK1 gene (rs35996865), a polymorphism in ROCK2 gene (rs10178332), a polymorphism in RhoA gene (rs2177268) and two polymorphisms in RhoC gene (rs11102522 and rs11538960) with SSc disease (p < 0.0022). In this study, association between SSc disease and Rho/Rho-kinase gene polymorphisms was investigated for the first time; significant associations between ROCK1, ROCK2, RhoA and RhoC gene polymorphisms and SSc disease were demonstrated. The results strongly suggest that this SNP may be an important risk factor for development of SSc. However, further validation of these findings in an independent cohort is necessary.

Entities:  

Keywords:  Early diagnosis; Pathogenesis; Rho/Rho-kinase; Systemic sclerosis

Mesh:

Substances:

Year:  2015        PMID: 26615410     DOI: 10.1007/s00296-015-3400-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  28 in total

1.  Urotensin-II in systemic sclerosis: a new peptide in pathogenesis.

Authors:  Yavuz Pehlivan; Ahmet Mesut Onat; Gazi Comez; Taner Babacan
Journal:  Clin Rheumatol       Date:  2011-01-28       Impact factor: 2.980

2.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Authors:  J H Korn; M Mayes; M Matucci Cerinic; M Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; J R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; A Herrick; P A Merkel; R Simms; C P Denton; D Furst; N Nguyen; M Gaitonde; Carol Black
Journal:  Arthritis Rheum       Date:  2004-12

3.  Selective or nonselective endothelin antagonists in porcine hypoxic pulmonary hypertension?

Authors:  A Franco-Cereceda; P Holm
Journal:  J Cardiovasc Pharmacol       Date:  1998       Impact factor: 3.105

4.  The efficiency of a urotensin II antagonist in an experimental lung fibrosis model.

Authors:  Ahmet Mesut Onat; Ibrahim Halil Turkbeyler; Yavuz Pehlivan; Tuncer Demir; Davut Sinan Kaplan; Seyithan Taysi; Ali Osman Ceribasi; Ediz Tutar; Bunyamin Kisacik
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 5.  Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.

Authors:  C Sunderkötter; G Riemekasten
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

6.  Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1.

Authors:  J J Maguire; R E Kuc; A P Davenport
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

7.  Chronic urotensin-II infusion induces diastolic dysfunction and enhances collagen production in rats.

Authors:  Lavinia Tran; Andrew R Kompa; Will Kemp; Arintaya Phrommintikul; Bing H Wang; Henry Krum
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

8.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

9.  Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation.

Authors:  Sandra B Haudek; Damon Gupta; Oliver Dewald; Robert J Schwartz; Lei Wei; JoAnn Trial; Mark L Entman
Journal:  Cardiovasc Res       Date:  2009-04-30       Impact factor: 10.787

10.  Expression of transforming growth factor-beta and platelet-derived growth factor in linear scleroderma.

Authors:  José Félix Restrepo; Renato Guzmán; Gerzaín Rodríguez; Antonio Iglesias
Journal:  Biomedica       Date:  2003-12       Impact factor: 0.935

View more
  7 in total

Review 1.  ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease.

Authors:  Alexandra Zanin-Zhorov; Bruce R Blazar
Journal:  Clin Immunol       Date:  2021-08-14       Impact factor: 10.190

2.  Genetic Association between TNFA Polymorphisms (rs1799964 and rs361525) and Susceptibility to Cancer in Systemic Sclerosis.

Authors:  Joanna Kosałka-Węgiel; Sabina Lichołai; Sylwia Dziedzina; Mamert Milewski; Piotr Kuszmiersz; Anna Rams; Jolanta Gąsior; Aleksandra Matyja-Bednarczyk; Helena Kwiatkowska; Mariusz Korkosz; Andżelika Siwiec; Paweł Koźlik; Agnieszka Padjas; Wojciech Sydor; Jerzy Dropiński; Marek Sanak; Jacek Musiał; Stanisława Bazan-Socha
Journal:  Life (Basel)       Date:  2022-05-07

Review 3.  New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.

Authors:  Alain Lescoat; John Varga; Marco Matucci-Cerinic; Dinesh Khanna
Journal:  Expert Opin Investig Drugs       Date:  2021-05-13       Impact factor: 6.498

4.  Genetic Susceptibility to Systemic Sclerosis in the Greek-Cypriot Population: A Pilot Study.

Authors:  Paraskevi Chairta; Savvas Psarelis; Kyriaki Michailidou; Christiana Demetriou; Sofia Symeonidou; Paschalis Nicolaou; Kyproula Christodoulou
Journal:  Genet Test Mol Biomarkers       Date:  2020-04-21

5.  Crystalline Silica Impairs Efferocytosis Abilities of Human and Mouse Macrophages: Implication for Silica-Associated Systemic Sclerosis.

Authors:  Alain Lescoat; Alice Ballerie; Marie Lelong; Yu Augagneur; Claudie Morzadec; Stéphane Jouneau; Patrick Jégo; Olivier Fardel; Laurent Vernhet; Valérie Lecureur
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

Review 6.  Rho GTPase signaling in rheumatic diseases.

Authors:  Ruijie Zeng; Zewei Zhuo; Yujun Luo; Weihong Sha; Hao Chen
Journal:  iScience       Date:  2021-12-14

7.  Genetic Risk and Phenotype Correlation of Primary Open-Angle Glaucoma Based on Rho-Kinase Gene Polymorphisms.

Authors:  Yong-Woo Kim; Eunoo Bak; Seoyoung Wy; Seung-Chan Lee; Yu-Jeong Kim; Young-Kook Kim; Ki-Ho Park; Jin-Wook Jeoung
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.